Kewei Chen

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Kewei Chen, Ke-wei Chen, Kewei W. Chen
Publication record
563 papers · 32,821 citations · H-index 89

PAPERS

Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease
202322 citationsauthor #10
Long‐term memory over 1‐week and markers of brain pathology in cognitively unimpaired individuals from a Colombian cohort with autosomal dominant Alzheimer’s disease
20230 citationsauthor #2
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.
202340 citationsauthor #36
Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction
202349 citationsauthor #62
Uncertainty-driven modality selection for data-efficient prediction of Alzheimer’s disease
20232 citationsauthor #3
Author Correction: Predicting Alzheimer’s disease progression using multi-modal deep learning approach
20230 citationsauthor #57
Early prediction of progression to Alzheimer’s disease using multi-modality neuroimages by a novel ordinal learning model ADPacer
20230 citationsauthor #4
Neuropsychological test performance of former American football players
202326 citationsauthor #28
Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.
202315 citationsauthor #5
Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort
20239 citationsauthor #4
From local properties to brain‐wide organization: A review of intraregional temporal features in functional magnetic resonance imaging data
20234 citationsauthor #3
A Shortened Model for Logan Reference Plot Implemented via the Self-Supervised Neural Network for Parametric PET Imaging
20237 citationsauthor #3
Self-Supervised Contrastive Learning to Predict Alzheimer’s Disease Progression with 3D Amyloid-PET
20232 citationsauthor #3
Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults
202334 citationsauthor #9
Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment
202320 citationsauthor #14
SORL1 rs1699102 Moderates the Effect of Sex on Language Network
20230 citationsauthor #6
Transfer learning based deep encoder decoder network for amyloid PET harmonization with small datasets
20231 citationsauthor #2
Regional Glymphatic Abnormality in Behavioral Variant Frontotemporal Dementia
202382 citationsauthor #6
Individualized network analysis: A novel approach to investigate tau PET using graph theory in the Alzheimer’s disease continuum
20232 citationsauthor #6
Longitudinal changes in surface based brain morphometry measures in amnestic mild cognitive impairment and Alzheimer’s Disease
202322 citationsauthor #3
Volumetric regional MRI and neuropsychological predictors of motor task variability in cognitively unimpaired, mild cognitive impairment, and probable Alzheimer's disease older adults.
202310 citationsauthor #3
A within-subject voxel-wise constant-block partial least squares correlation method to explore MRI-based brain structure–function relationship
20230 citationsauthor #2
Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment
202314 citationsauthor #3
A Surface-Based Federated Chow Test Model for Integrating APOE Status, Tau Deposition Measure, and Hippocampal Surface Morphometry
20231 citationsauthor #7
Increased spatial extent of cerebral tau PET elevations in former NFL and college football players from the DIAGNOSE CTE Research Project
20230 citationsauthor #1
A longitudinal 18F‐FDG PET study in asymptomatic stage of genetic Creutzfeldt–Jakob disease
20230 citationsauthor #6
Naoxin’an capsules protect brain function and structure in patients with vascular cognitive impairment
20234 citationsauthor #3
Sex differences in cognitive resilience in preclinical autosomal‐dominant Alzheimer's disease carriers and non‐carriers: Baseline findings from the API ADAD Colombia Trial
202220 citationsauthor #9
MRI signatures of Brain Age in the Alzheimer’s disease continuum
20222 citationsauthor #7
Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players
202220 citationsauthor #31
Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease
20220 citationsauthor #264
Effects of age on the hippocampus and verbal memory in adults with autism spectrum disorder: Longitudinal versus cross‐sectional findings
202231 citationsauthor #4
Risk scores of incident mild cognitive impairment in a Beijing community-based older cohort
20222 citationsauthor #5
Effect of APOE4 on Plasma Phospho‐tau 217 and Neurofilament Light in the PSEN1 E280A Autosomal Dominant Alzheimer’s Disease Colombian Kindred
20220 citationsauthor #4
Serotonin Reuptake Inhibitors are Associated with Less Amyloid‐β Burden Spatial Extent in Military Veterans with only PTSD, but not with TBI or Comorbid PTSD/TBI: Preliminary PET Findings from ADNI‐DOD Project
20220 citationsauthor #1
Deep residual inception encoder‐decoder network for amyloid PET harmonization
202213 citationsauthor #11
Reconfigured metabolism brain network in asymptomatic microtubule-associated protein tau mutation carriers: a graph theoretical analysis
202210 citationsauthor #10
Differential impact of body mass index and leptin on baseline and longitudinal positron emission tomography measurements of the cerebral metabolic rate for glucose in amnestic mild cognitive impairment
20225 citationsauthor #2
Transfer Learning based Deep Encoder Decoder Network for Amyloid PET Harmonization with Small Datasets
20221 citationsauthor #2
Preliminary findings of accelerated visual memory decline and baseline brain correlates in middle-age and older adults with autism: The case for hippocampal free-water
202218 citationsauthor #4
The characteristics of glucose metabolism and functional connectivity in posterior default network during nondemented aging: relationship with executive function performance.
20225 citationsauthor #10
Early prediction of the Alzheimer’s disease risk using Tau-PET and machine learning
20220 citationsauthor #4
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
2022215 citationsauthor #27
White matter hyperintensities are a prominent feature of autosomal dominant Alzheimer’s disease that emerge prior to dementia
202229 citationsauthor #3
Addressing imaging accessibility by cross-modality transfer learning
20220 citationsauthor #3
A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial
202214 citationsauthor #18
Successful or pathological cognitive aging? Converging into a "frontal preservation, temporal impairment (FPTI)" hypothesis.
202216 citationsauthor #8
Tau as a biomarker of cognitive impairment and neuropsychiatric symptom in Alzheimer's disease
202219 citationsauthor #4
Plasma neurofilament light chain in cognitively unimpaired late middle‐aged & older adult APOE ε4 homozygotes, heterozygotes, & non‐carriers from the Arizona APOE Cohort
20220 citationsauthor #10
A longitudinal 18F-FDG PET/MRI study in asymptomatic stage of genetic Creutzfeldt–Jakob disease linked to G114V mutation
20223 citationsauthor #7
Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease
202237 citationsauthor #45
Predicting the pace of MCI progression to AD based on multi‐modality neuroimaging data by a novel hybrid ordinal learning algorithm
20220 citationsauthor #4
A new flortaucipir PET biomarker based on graph theory for early detection of CTE in former American football players
20220 citationsauthor #4
Improved Prediction of Beta-Amyloid and Tau Burden Using Hippocampal Surface Multivariate Morphometry Statistics and Sparse Coding
20220 citationsauthor #9
Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume
202225 citationsauthor #53
Head‐to‐Head Comparison of Four Plasma Phospho‐Tau Immunoassays in the Neuropathological Diagnosis of Alzheimer’s Disease
20221 citationsauthor #7
Investigating the Effect of Tau Deposition and Apoe on Hippocampal Morphometry in Alzheimer’s Disease: A Federated Chow Test Model
20222 citationsauthor #5
A machine learning framework with uncertainty‐driven neuroimaging modality selection for data‐efficient prediction of Alzheimer’s Disease
20221 citationsauthor #3
Reproductive health data and its relationship to baseline brain imaging and cognitive measurements in cognitively unimpaired female PSEN1 E280A mutation carriers and non‐carriers from the API ADAD Trial
20220 citationsauthor #18
Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease
202241 citationsauthor #12
Hemispheric asymmetry and atypical lobar progression of Alzheimer‐type tauopathy
20223 citationsauthor #14
Cognition Before and After COVID-19 Disease in Older Adults: An Exploratory Study
20224 citationsauthor #3
Contributions of early-life cognitive reserve and late-life leisure activity to successful and pathological cognitive aging
202216 citationsauthor #4
Unified Parkinson’s Disease Rating Scale (UPDRS) motor score subscale trajectories in Dementia with Lewy Bodies and Parkinson Disease Dementia in a community autopsy cohort
20220 citationsauthor #4
An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease
202237 citationsauthor #62
Associations between different FDG PET indices and clinical ratings in cognitively unimpaired older adults
20210 citationsauthor #2
Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke
202112 citationsauthor #7
Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding
20216 citationsauthor #11
Disrupted anterior and posterior hippocampal structural networks correlate impaired verbal memory and spatial memory in different subtypes of mild cognitive impairment
202111 citationsauthor #3
Limitations of clinical trial sample size estimate by subtraction of two measurements
20214 citationsauthor #1
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares
202123 citationsauthor #13
Sex Differences in Cortical Morphometry and White Matter Microstructure During Brain Aging and Their Relationships to Cognition.
202118 citationsauthor #3
Predicting Tau accumulation in cerebral cortex with multivariate MRI morphometry measurements, sparse coding, and correntropy
20212 citationsauthor #9
Community-based Model for Dementia Risk Screening: The Beijing Aging Brain Rejuvenation Initiative (BABRI) Brain Health System.
202113 citationsauthor #4
Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
202184 citationsauthor #82
Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project
20210 citationsauthor #43
A Computational Monte Carlo Simulation Strategy to Determine the Temporal Ordering of Abnormal Age Onset Among Biomarkers of Alzheimer's Disease
202115 citationsauthor #2
Studying APOE ɛ4 Allele Dose Effects with a Univariate Morphometry Biomarker
20211 citationsauthor #12
Closer correlations between florbetapir PET measurements of amyloid plaque burden using a cerebral white matter reference region and Alzheimer’s disease‐related hypometabolism
20210 citationsauthor #13
Improved comparability between measurements of mean cortical amyloid plaque burden derived from different PET tracers using multiple regions‐of‐interest and machine learning
20211 citationsauthor #1
Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization
202122 citationsauthor #54
Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort
20218 citationsauthor #3
Deep Residual Inception Encoded‐Decoder Neural Network for amyloid PET harmonization
20210 citationsauthor #9
Associations between plasma p‐tau217, in vivo brain pathology and cognition in individuals with autosomal‐dominant Alzheimer’s disease: Findings from the Colombia‐Boston (COLBOS) biomarker study
20210 citationsauthor #5
Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
20219 citationsauthor #2
Deep learning-based brain transcriptomic signatures associated with the neuropathological and clinical severity of Alzheimer’s disease
202123 citationsauthor #2
Accelerated Brain Aging in Amnestic Mild Cognitive Impairment: Relationships with Individual Cognitive Decline, Risk Factors for Alzheimer Disease, and Clinical Progression.
202120 citationsauthor #5
Differences of ASL‐MRI measured cerebral blood flow among patients with AD, patients with MCI and cognitively umimpaired individuals
20213 citationsauthor #3
Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease
20216 citationsauthor #45
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
202140 citationsauthor #81
Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation Initiative
202147 citationsauthor #21
Four distinct trajectories of tau deposition identified in Alzheimer’s disease
2021571 citationsauthor #48
Cortical thickness across the lifespan in a Colombian cohort with autosomal‐dominant Alzheimer's disease: A cross‐sectional study
20216 citationsauthor #4
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
202148 citationsauthor #43
The trend of disruption in the functional brain network topology of Alzheimer’s disease
202136 citationsauthor #136
Federated Morphometry Feature Selection for Hippocampal Morphometry Associated Beta-Amyloid and Tau Pathology
202114 citationsauthor #10
CSF amyloid‐beta, tau, and neurodegenerative and inflammatory biomarkers in cognitively unimpaired late middle‐aged and older adult APOE ε4 homozygotes, heterozygotes, and non‐carriers from the Arizona APOE Cohort
20211 citationsauthor #8
PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer’s disease-causing Presenilin-1 E280A mutation carriers
202117 citationsauthor #25
Deep learning‐based identification of transcriptomic signatures associated with Alzheimer’s disease progression
20211 citationsauthor #3
Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
202159 citationsauthor #98

TIMELINE

1995 101 citations

1996 1,342 citations

1997 188 citations

1998 324 citations

1999 130 citations

2000 1,100 citations

2001 701 citations

2002 913 citations

2003 1,199 citations

2004 57 citations

2005 432 citations

2006 1,457 citations

2007 813 citations

2008 722 citations

2009 2,330 citations

2010 2,020 citations

2011 1,847 citations

2012 1,741 citations

2013 1,642 citations

2014 1,087 citations

2015 3,769 citations

2016 2,358 citations

2017 847 citations

2018 1,209 citations

2019 1,336 citations

2020 1,088 citations

2021 1,123 citations

2022 590 citations

2023 366 citations

Unknown 32 citations

Kewei Chen

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT